questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines du sang
Immunoprotéines
Protéines du système du complément
Complément C3
Complément C3b
Complément C3c
Complément C3c : Questions médicales fréquentes
Termes MeSH sélectionnés :
Extracellular Signal-Regulated MAP Kinases
Diagnostic
5
Compléments
Tests de laboratoire
Compléments
Tests de laboratoire
Maladies auto-immunes
Inflammation
Marqueurs biologiques
Pathologies
Système du complément
Diagnostic
Symptômes
5
Système immunitaire
Symptômes
Prévention
5
Prévention
Maladies chroniques
Vaccins
Système immunitaire
Stress
Système immunitaire
Examens médicaux
Prévention
Traitements
5
Immunothérapie
Traitement
Médicaments immunosuppresseurs
Compléments
Suivi médical
Compléments
Alimentation
Système immunitaire
Transfusions sanguines
Compléments
Complications
5
Infections
Maladies auto-immunes
Complications
Inflammation
Maladies cardiovasculaires
Risques
Facteurs de risque
5
Facteurs de risque
Maladies auto-immunes
Antécédents familiaux
Maladies immunitaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Complément C3c : Questions médicales les plus fréquentes",
"headline": "Complément C3c : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Complément C3c : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Complément C3c"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Complément C3b",
"url": "https://questionsmedicales.fr/mesh/D003179",
"about": {
"@type": "MedicalCondition",
"name": "Complément C3b",
"code": {
"@type": "MedicalCode",
"code": "D003179",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.124.486.274.250.260"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Complément C3c",
"alternateName": "Complement C3c",
"code": {
"@type": "MedicalCode",
"code": "D015932",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marinos C Dalakas",
"url": "https://questionsmedicales.fr/author/Marinos%20C%20Dalakas",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. mdalakas@med.uoa.gr."
}
},
{
"@type": "Person",
"name": "Shruti Chaturvedi",
"url": "https://questionsmedicales.fr/author/Shruti%20Chaturvedi",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Robert A Brodsky",
"url": "https://questionsmedicales.fr/author/Robert%20A%20Brodsky",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Keith R McCrae",
"url": "https://questionsmedicales.fr/author/Keith%20R%20McCrae",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH."
}
},
{
"@type": "Person",
"name": "Martin Kohn",
"url": "https://questionsmedicales.fr/author/Martin%20Kohn",
"affiliation": {
"@type": "Organization",
"name": "Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy.",
"datePublished": "2023-04-10",
"url": "https://questionsmedicales.fr/article/37108173",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24087012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lymphocytic Extracellular Signal-Regulated Kinase Dysregulation in Autism Spectrum Disorder.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36638885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaac.2022.09.437"
}
},
{
"@type": "ScholarlyArticle",
"name": "Extracellular Signal-Regulated Kinases Play Essential but Contrasting Roles in Osteoclast Differentiation.",
"datePublished": "2023-10-19",
"url": "https://questionsmedicales.fr/article/37895023",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms242015342"
}
},
{
"@type": "ScholarlyArticle",
"name": "Activation of the mitogen-activated protein kinase-extracellular signal-regulated kinase pathway in childhood B-cell acute lymphoblastic leukemia.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35593589",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pbc.29771"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37894903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms242015223"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines du sang",
"item": "https://questionsmedicales.fr/mesh/D001798"
},
{
"@type": "ListItem",
"position": 5,
"name": "Immunoprotéines",
"item": "https://questionsmedicales.fr/mesh/D007162"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines du système du complément",
"item": "https://questionsmedicales.fr/mesh/D003165"
},
{
"@type": "ListItem",
"position": 7,
"name": "Complément C3",
"item": "https://questionsmedicales.fr/mesh/D003176"
},
{
"@type": "ListItem",
"position": 8,
"name": "Complément C3b",
"item": "https://questionsmedicales.fr/mesh/D003179"
},
{
"@type": "ListItem",
"position": 9,
"name": "Complément C3c",
"item": "https://questionsmedicales.fr/mesh/D015932"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Complément C3c - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Complément C3c",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Complément C3c",
"description": "Comment mesurer le complément C3c ?\nQuels tests sont associés au C3c ?\nQuand évaluer le C3c ?\nLe C3c est-il un marqueur de maladie ?\nQuel rôle joue le C3c dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Extracellular+Signal-Regulated+MAP+Kinases#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Complément C3c",
"description": "Quels symptômes sont liés à un faible C3c ?\nUn C3c élevé indique-t-il des symptômes ?\nLe C3c affecte-t-il la fatigue ?\nY a-t-il des symptômes spécifiques au C3c ?\nLe C3c est-il lié à des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Extracellular+Signal-Regulated+MAP+Kinases#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Complément C3c",
"description": "Comment prévenir les anomalies du C3c ?\nLe vaccin influence-t-il le C3c ?\nY a-t-il des habitudes à éviter ?\nLe stress affecte-t-il le C3c ?\nDes examens réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Extracellular+Signal-Regulated+MAP+Kinases#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Complément C3c",
"description": "Comment traiter un faible C3c ?\nDes médicaments affectent-ils le C3c ?\nLe C3c nécessite-t-il un suivi ?\nPeut-on augmenter le C3c naturellement ?\nLes transfusions affectent-elles le C3c ?",
"url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Extracellular+Signal-Regulated+MAP+Kinases#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Complément C3c",
"description": "Quelles complications peuvent survenir avec un C3c bas ?\nUn C3c élevé cause-t-il des complications ?\nLe C3c affecte-t-il la guérison des blessures ?\nY a-t-il des risques de thrombose liés au C3c ?\nLe C3c influence-t-il les maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Extracellular+Signal-Regulated+MAP+Kinases#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Complément C3c",
"description": "Quels facteurs augmentent le risque de C3c anormal ?\nL'âge influence-t-il le C3c ?\nLe sexe joue-t-il un rôle dans le C3c ?\nLe mode de vie affecte-t-il le C3c ?\nLes antécédents familiaux influencent-ils le C3c ?",
"url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Extracellular+Signal-Regulated+MAP+Kinases#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le complément C3c ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le complément C3c est mesuré par un test sanguin spécifique en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont associés au C3c ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de C3c sont souvent associés à des dosages de C3 et C4."
}
},
{
"@type": "Question",
"name": "Quand évaluer le C3c ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le C3c est évalué lors de suspicion de maladies auto-immunes ou inflammatoires."
}
},
{
"@type": "Question",
"name": "Le C3c est-il un marqueur de maladie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de C3c peuvent indiquer des pathologies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le C3c dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le C3c aide à évaluer l'activité du système du complément dans diverses conditions."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à un faible C3c ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible C3c peut entraîner des infections fréquentes et des inflammations."
}
},
{
"@type": "Question",
"name": "Un C3c élevé indique-t-il des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un C3c élevé peut être associé à des symptômes d'inflammation ou d'infection."
}
},
{
"@type": "Question",
"name": "Le C3c affecte-t-il la fatigue ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de C3c peuvent contribuer à la fatigue liée à l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques au C3c ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le C3c n'a pas de symptômes spécifiques, mais reflète l'état immunitaire."
}
},
{
"@type": "Question",
"name": "Le C3c est-il lié à des douleurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de C3c peuvent être associés à des douleurs inflammatoires."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies du C3c ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et gérer les maladies chroniques aide à prévenir les anomalies."
}
},
{
"@type": "Question",
"name": "Le vaccin influence-t-il le C3c ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins peuvent stimuler le système immunitaire, influençant potentiellement le C3c."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et une mauvaise alimentation peut aider à maintenir un C3c normal."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le C3c ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber le système immunitaire et affecter le C3c."
}
},
{
"@type": "Question",
"name": "Des examens réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter des anomalies du C3c tôt."
}
},
{
"@type": "Question",
"name": "Comment traiter un faible C3c ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, souvent par immunothérapie."
}
},
{
"@type": "Question",
"name": "Des médicaments affectent-ils le C3c ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments immunosuppresseurs peuvent réduire les niveaux de C3c."
}
},
{
"@type": "Question",
"name": "Le C3c nécessite-t-il un suivi ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est recommandé pour surveiller les niveaux de C3c."
}
},
{
"@type": "Question",
"name": "Peut-on augmenter le C3c naturellement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent soutenir le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les transfusions affectent-elles le C3c ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les transfusions peuvent influencer les niveaux de C3c en fonction des composants."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec un C3c bas ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un C3c bas peut entraîner des infections récurrentes et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Un C3c élevé cause-t-il des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un C3c élevé peut être lié à des complications inflammatoires et des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le C3c affecte-t-il la guérison des blessures ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de C3c peuvent retarder la guérison en perturbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de thrombose liés au C3c ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de C3c peuvent être associés à un risque accru de thrombose."
}
},
{
"@type": "Question",
"name": "Le C3c influence-t-il les maladies cardiovasculaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de C3c peuvent être liés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de C3c anormal ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies auto-immunes, infections chroniques et certains médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le C3c ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut affecter les niveaux de C3c, souvent en raison de changements immunitaires."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le C3c ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des différences hormonales peuvent influencer les niveaux de C3c entre les sexes."
}
},
{
"@type": "Question",
"name": "Le mode de vie affecte-t-il le C3c ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent affecter le C3c."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le C3c ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies immunitaires peuvent augmenter le risque de C3c anormal."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. mdalakas@med.uoa.gr.
Neuroimmunology Unit, Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece. mdalakas@med.uoa.gr.
Publications dans "Complément C3c" :
4 publications dans cette catégorie
Affiliations :
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publications dans "Complément C3c" :
4 publications dans cette catégorie
Affiliations :
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publications dans "Complément C3c" :
3 publications dans cette catégorie
Affiliations :
Division of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Institute for Laboratory Animal Science, Medical School Hannover, Hannover, Germany.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Translational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, Skaggs School of Pharmacy, University of Colorado Anschutz Medical Center, Aurora, CO, USA; Colorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Center, Aurora, CO, USA.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Radboud Institute for Molecular Life Sciences, Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
Linnaeus Centre for Biomaterials Chemistry, Linnaeus University, Kalmar, Sweden.
Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
BMT Unit, Hematology Department, G. Papanicolaou Hospital, Thessaloniki, Greece.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, United States.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
Department of Nephrology Dialysis and Transplantation, University Hospital of Strasbourg, Strasbourg, France.
Publications dans "Complément C3c" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche des Cordeliers, Inserm UMR S1138, Paris, France.
Service d'Immunologie, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
Publications dans "Complément C3c" :
Prostaglandin F2α (PGF2α), the first-line anti-glaucoma medication, can cause the deepening of the upper eyelid sulcus due to orbital lipoatrophy. However, the pathogenesis of Graves' ophthalmopathy (...
Extracellular signal-regulated kinase (ERK1/2) is a conserved central intracellular signaling cascade involved in many aspects of neuronal development and plasticity. Converging evidence support inves...
Study participants included 67 individuals with ASD (3-25 years of age), 65 age- and sex-matched typical developing control (TDC) subjects, and 36 age-, sex-, and IQ-matched developmental disability c...
The ASD group (mean = 5.81 minutes; SD = 1.5) had a significantly lower (more rapid) mean ERK1/2 T...
Our findings indicate that lymphocytic ERK1/2 activation kinetics are dysregulated in persons with ASD, marked by more rapid early phase activation. Group differences in ERK1/2 activation kinetics app...
We worked to ensure sex and gender balance in the recruitment of human participants. We actively worked to promote sex and gender balance in our author group. The author list of this paper includes co...
Bone homeostasis is regulated by the balanced actions of osteoblasts that form the bone and osteoclasts (OCs) that resorb the bone. Bone-resorbing OCs are differentiated from hematopoietic monocyte/ma...
RAS mutations are frequently observed in childhood B-cell acute lymphoblastic leukemia (B-ALL) and previous studies have yielded conflicting results as to whether they are associated with a poor outco...
As an important cancer therapeutic target, extracellular signal-regulated kinases (ERK) are involved in triggering various cellular responses in tumors. Regulation of the ERK signaling pathway by the ...
Mitogen-activated extracellular signal-regulated kinase 1 and 2 (MEK1/2) are the critical components of the mitogen-activated protein kinase/extracellular signal-regulated kinase 1 and 2 (MAPK/ERK1/2)...
Extracellular signal-regulated kinase (ERK) has been recognized as a critical regulator in various physiological and pathological processes. Extensive research has elucidated the signaling mechanisms ...
Extracellular signal-regulated protein kinase 1/2 (ERK1/2), the only known substrate of MEK1/2, is located downstream of the RAS-RAF-MEK-ERK (MAPK) pathway and is associated with the abnormal activati...
Microtubule-associated protein 2 (MAP2) is an important neuronal target of extracellular signal-regulated kinase 2 (ERK2) involved in Raf signaling pathways, but mechanistic details of MAP2 phosphoryl...
Cannabidiol exerts its anti-inflammatory and anti-oxidant activities in various human cells. However, its proliferative effect has not been extrapolated to human gingival fibroblasts (HGFs). This stud...
HGFs, characterized by their CD73, CD90, and CD105 expressions by flow cytometry, were treated with cannabidiol at 0.01-30 μM. The cytotoxicity was determined by the MTT assay, while the proliferative...
No toxicity was found in HGFs treated with any doses of cannabidiol up to 30 μM. The mean percentage of cell proliferation was significantly enhanced by treatment with cannabidiol at 3 or 10 μM (p < ....
Treatment with cannabidiol at non-toxic doses promotes HGFs' proliferation and migration....